Anti-fungal activity of Carica papaya leaf extract against candida albicans and its synergy with fluconazole: an in-vitro study
Keywords:Carica papaya leaf, Synergism, Candida albicans
Background: In this study objectives were to evaluate the antifungal activity in increasing concentrations of ethanolic extract and aqueous extract of Carica papaya against Candida albicans and to assess the synergistic activity of ethanolic extract of Caricia papaya with flucanazole as a potential antifungal.
Methods: The aim of the study was to evaluate the antifungal activity in increasing concentrations, 500 µl/ml, 750 µl/ml and 1000 µl/ml of ethanolic extract and aqueous extract of caricia papaya against Candida albicans and the synergistic activity with Fluconazole was assessed by observing the zone of inhibition in agar disc diffusion assay and by observing the turbidity in minimum inhibitory concentration (MIC) assay.
Results: It was observed that ethanolic extract of Carica papaya leaf showed significant antifungal activity in higher concentration of 1000µg/ml with zone diameter of 11.97±0.15 mm in disc diffusion assay and MIC of 350 µg/ml. The ethanolic extract of Carica papaya leaf with fluconazole showed synergistic activity with zone diameter of 13.6±0.45 mm in disc diffusion assay and MIC was 125µg/ml, whereas the standard drug Fluconazole’s zone of inhibiton was 12.83±0.9 in disc diffusion and MIC was 500 µg/ml.
Conclusions: From this study, we can safely conclude that the Carica papaya leaf extract has a significant antifungal property and exhibit synergistic effect when used with fluconazole.
Mello VJ, Gomes MT, Lemos FO, Delfino JL, Andrade SP, Lopes MT, et al. The gastric ulcer protective and healing role of cysteine proteinases from Carica candamarcensis. Phytomedicine. 2008;15237-44.
Otsuki N, Dang NH, Kumagai E, Kondo A, Iwata S, Morimoto C. Aqueous extract of Carica papaya leaves exhibits anti-tumor activity and immunomodulatory effects. J Ethnopharmacol. 2010;127(3):760-7.
Sugar AM, Alsip SG, Galgiani JN, Graybill JR, Dismukes WE, Claud GA, et al. Pharmacology and toxicity of high-dose ketoconazole. Antimicrob Agent Chemother. 1987;31:1874-8.
Wu TC. On the development of antifungal agents: perspective of the US Food and Drug Administration. Clin Infect Dis. 1994;19:S54-8.
Walsh TJ, Gonzalez C, Lyman CA, Chanock SJ, Pizzo PA. Invasive fungal infections in children:recent advances in diagnosis and treatment. Adv Pediatr Infect Dis. 1996;11:187-290.
6. Eggimann, P., Garbino, J. & Pitte, D. (2003). Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis 3, 685–702.
Filler SG, Sheppard DC. Fungal invasion of normally non-phagocytic host cells. PLoS Pathog. 200629;2(12):e129.
Brammer KW, Farrow PR, Faulkner JK. Pharmacokinetics and tissue penetration of fluconazole in humans. Rev Infect Disea. 1990;12(3):S318-26.
Pinto E, Vale-Silva L, Cavaleiro C, Salgueiro L. Antifungal activity of the clove essential oil from Syzygium aromaticum on Candida, Aspergillus and dermatophyte species. J Med Microbiol. 2009;58(11):1454-62.
Ghannoum MA, Fu Y, Ibrahim AS, Mortara LA, Shafiq MC, Edwards JE, et al. In vitro determination of optimal antifungal combinations against Cryptococcus neoformans and Candida albicans. Antimicrob Agents Chemother. 1995;39(11):2459-65.
Khan JA, Yadav J, Srivastava Y, Pal PK. In vitro evaluation of antimicrobial properties of Carica papaya. Int J Biol, Pharm Alli Sci. 2012;1(7):933-45.
Baskaran C, Velu S, Kumaran K. The efficacy of Carica papaya leaf extract on some bacterial and a fungal strain by well diffusion method. Asia Pacif J Tropic Dise. 2012;2:S658-62.